PeterSKleinMD
Hematology • Philadelphia, PAAssociate Professor, Medicine, Perelman School of Medicine
Are you Dr. Klein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
# 15
Philadelphia, PA 19104Phone+1 215-662-3914
Summary
- Dr. Peter Klein, MD is a hematologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and is an Associate Professor at Perelman School of Medicine.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2005
Massachusetts General HospitalResidency, Internal Medicine, 1988 - 1991
Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
PA State Medical License 1995 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2003
- Investigator Alumnus Howard Hughes Medical Institute, 1995
Publications & Presentations
PubMed
- A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley, Ryan M Morrow, Kevin A Janssen
The Journal of Clinical Investigation. 2024-05-07 - A mitochondrial surveillance mechanism activated bymutations in hematologic malignancies.Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley, Ryan Morrow, Kevin Janssen
Biorxiv. 2024-04-23 - Expansion of human hematopoietic stem cells by inhibiting translation.Chenchen Li, Hanna Shin, Dheeraj Bhavanasi, Mai Liu, Xiang Yu
Biorxiv. 2023-11-29
Grant Support
- Targeting WNT And Mtor To Expand Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2011–2012
- Regulating Hematopoietic Stem Cell Homeostasis Through GSK-3National Heart, Lung, And Blood Institute2011–2012
- A Molecular Mechanism For Lithium ActionNational Institute Of Mental Health2001–2010
- Early Activation Of The Zygotic GenomeNational Institute Of General Medical Sciences2006–2009
- Phase II Trial Of Valproic Acid In MyelodysplasiaNational Cancer Institute2005–2006
- A Novel Molecular Target Of Valproic AcidNational Institute Of Mental Health2002–2006
- Molecular Mechanism For Lithium ActionNational Institute Of Mental Health1998–2000
- Molecular Target Of Lithium In Affective DisordersNational Institute Of Mental Health1997–1998
